Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dr Reddys Labs
Dr Reddys Labs
BSE: 500124NSE: DRREDDYISIN: INE089A01023

25th-Jan-2013 11:50Source: BSE

Dr Reddys Labs - Dr. Reddy's announces the Launch of Desloratadine ODT (Orally Disintegrating Tablets)

Dr Reddys Laboratories has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex Reditabs in the US markets on January 24, 2013.

More Announcements on:

20th-Jun-2017 14:41Source: NSE

Dr. Reddy's Laboratories Limited

20th-Jun-2017 11:39Source: NSE

Dr. Reddy's Laboratories Limited

20th-Jun-2017 11:05Source: BSE

Dr Reddys Labs - Updates

16th-Jun-2017 18:09Source: BSE

Dr Reddys Labs - Updates

15th-Jun-2017 11:38Source: NSE

Dr. Reddy's Laboratories Limited

15th-Jun-2017 11:27Source: BSE

Dr Reddys Labs - Updates

14th-Jun-2017 17:52Source: NSE

Dr. Reddy's Laboratories Limited

14th-Jun-2017 08:26Source: NSE

Dr. Reddy's Laboratories Limited

1 2 3 4 5 Next >>
Sections
Follow us on
Available On